Medical School

Hematology, Oncology and Transplantation

Department of Medicine

Nelli Bejanyan, MD

UMP - Image - Size 3 - Bejanyan, Nelli

Academic Title

Assistant Professor

Clinical Title

Hematologist / Oncologist


  • Blood and Marrow Transplantation
  • Hematology/Oncology


  • Blood and Marrow Transplant
  • Masonic Cancer Clinic


Medical School
Yerevan State Medical University, Yerevan, Armenia
Cleveland Clinic, Cleveland, OH (Internal Medicine)
Worchester Medical Center, Worchester, MA
Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH (Bone Marrow Failure Disorders, Hematology and Medical Oncology)

Administrative Contact

E: Kristin Blomquist
(612) 625-8942
F: (612) 625-6919

Mailing Address

Division of Hematology, Oncology and Transplantation
420 Delaware Street SE, MMC 480
Minneapolis, MN 55455

Bio Statement

Dr. Bejanyan completed Internal Medicine residency training at the Cleveland Clinic Ohio in 2008. She subsequently completed a clinical and research fellowship in Bone Marrow Failure Disorders in 2009 followed by fellowship training in Hematology and Medical Oncology from the Cleveland Clinic in 2012.

Leadership Roles
  • Member, American Medical Association (2007-present)
  • Associate Member, American Society of Bone Marrow Transplantation (2011-present)
  • Associate Member, American Society of Hematology (2010-present)
  • Associate Member, American Society of Clinical Oncology (2010-present)
  • Summa Cum Laude/Golden Medal, Yerevan State Medical University
  • Mkhitar Heratsi Award: “Best Medical Student, Class of 1993,” Armenia
  • Bejanyan N, Rogosheske J, Defor T, Lazaryan A, Esbaum K, Holtan S, Arora M, MacMillan M, Weisdorf D, Jacobson P, Wagner J and Brunstein C. Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-Versus-Host Disease in Reduced Intensity Conditioning Double Umbilical Cord Blood Transplantation. (Manuscript accepted for publication, Biol Blood Marrow Transplant 2015; Reference: YBBMT53771)
  • Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, Blazar BR, MacMillan ML, Weisdorf DJ. Composite endpoint of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015 Jan 15. pii: blood-2014-10-609032. [Epub ahead of print]
  • Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, deLima M, Bunjes DW, Zhang MG. “Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.” Biol Blood Marrow Transplant. 2014 Nov 15. Pii:S1083-8791(14)00679-X. [Epub ahead of print] PMID: 25460355
  • Warlick ED, Peffault de Latour R, Shanley R, Robin M, Bejanyan N, Xhaard A, Brunstein CG, Sicre de Fontbrune F, Ustun C, Weisdorf DJ, Socie G. “Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia: Similar Outcomes Regardless of Donor Type.” Biol Blood Marrow Transplant. 2014 Nov 6. Pii:S1083-8791(14)00669-7 [Epub ahead of print] PMID: 25452032
  • Bejanyan N, Oran B, Shanley R, Warlick E, Ustun C, Vercellotti G, Verneris M, Wagner JE, Weisdorf D, Brunstein C. Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplant. 2014 Aug;49(8):1029-35.
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on November 24, 2015